You are here Home Resources and guidance Sponsors Gilead Sciences Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type Australian public assessment report (AusPar) (1) Date 2019 (1) Search Sponsor content1 result(s) found, displaying 1 to 1 AusPAR: Bictegravir / emtricitabine / tenofovir alafenamide 24 September 2019 Australian public assessment report (AusPar) Australian Public Assessment for Bictegravir / emtricitabine / tenofovir alafenamide
AusPAR: Bictegravir / emtricitabine / tenofovir alafenamide 24 September 2019 Australian public assessment report (AusPar) Australian Public Assessment for Bictegravir / emtricitabine / tenofovir alafenamide